Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 2
1980 2
1982 1
1983 2
1984 2
1985 2
1988 1
1992 4
1994 1
1996 1
1997 2
2003 1
2012 1
2013 2
2014 1
2016 1
2017 3
2018 5
2019 8
2020 16
2021 20
2022 18
2023 21
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

111 results

Results by year

Filters applied: . Clear all
Page 1
Super enhancer regulation of cytokine-induced chemokine production in alcoholic hepatitis.
Liu M, Cao S, He L, Gao J, Arab JP, Cui H, Xuan W, Gao Y, Sehrawat TS, Hamdan FH, Ventura-Cots M, Argemi J, Pomerantz WCK, Johnsen SA, Lee JH, Gao F, Ordog T, Mathurin P, Revzin A, Bataller R, Yan H, Shah VH. Liu M, et al. Among authors: argemi j. Nat Commun. 2021 Jul 27;12(1):4560. doi: 10.1038/s41467-021-24843-w. Nat Commun. 2021. PMID: 34315876 Free PMC article.
CRIg on liver macrophages clears pathobionts and protects against alcoholic liver disease.
Duan Y, Chu H, Brandl K, Jiang L, Zeng S, Meshgin N, Papachristoforou E, Argemi J, Mendes BG, Wang Y, Su H, Sun W, Llorente C, Hendrikx T, Liu X, Hosseini M, Kisseleva T, Brenner DA, Bataller R, Ramachandran P, Karin M, Fu W, Schnabl B. Duan Y, et al. Among authors: argemi j. Nat Commun. 2021 Dec 9;12(1):7172. doi: 10.1038/s41467-021-27385-3. Nat Commun. 2021. PMID: 34887405 Free PMC article.
Alcoholic Hepatitis.
Gougol A, Clemente-Sanchez A, Argemi J, Bataller R. Gougol A, et al. Among authors: argemi j. Clin Liver Dis (Hoboken). 2021 Sep 19;18(2):90-95. doi: 10.1002/cld.1092. eCollection 2021 Aug. Clin Liver Dis (Hoboken). 2021. PMID: 34584675 Free PMC article. Review. No abstract available.
Hepatocyte dedifferentiation profiling in alcohol-related liver disease identifies CXCR4 as a driver of cell reprogramming.
Aguilar-Bravo B, Ariño S, Blaya D, Pose E, Martinez García de la Torre RA, Latasa MU, Martínez-Sánchez C, Zanatto L, Sererols-Viñas L, Cantallops-Vilà P, Affo S, Coll M, Thillen X, Dubuquoy L, Avila MA, Argemi J, Paz AL, Nevzorova YA, Cubero FJ, Bataller R, Lozano JJ, Ginès P, Mathurin P, Sancho-Bru P. Aguilar-Bravo B, et al. Among authors: argemi j. J Hepatol. 2023 Sep;79(3):728-740. doi: 10.1016/j.jhep.2023.04.013. Epub 2023 Apr 23. J Hepatol. 2023. PMID: 37088308
Loss of hepatocyte identity following aberrant YAP activation: A key mechanism in alcoholic hepatitis.
Bou Saleh M, Louvet A, Ntandja-Wandji LC, Boleslawski E, Gnemmi V, Lassailly G, Truant S, Maggiotto F, Ningarhari M, Artru F, Anglo E, Sancho-Bru P, Corlu A, Argemi J, Dubois-Chevalier J, Dharancy S, Eeckhoute J, Bataller R, Mathurin P, Dubuquoy L. Bou Saleh M, et al. Among authors: argemi j. J Hepatol. 2021 Oct;75(4):912-923. doi: 10.1016/j.jhep.2021.05.041. Epub 2021 Jun 12. J Hepatol. 2021. PMID: 34129887 Free article.
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study.
Zeng Q, Klein C, Caruso S, Maille P, Allende DS, Mínguez B, Iavarone M, Ningarhari M, Casadei-Gardini A, Pedica F, Rimini M, Perbellini R, Boulagnon-Rombi C, Heurgué A, Maggioni M, Rela M, Vij M, Baulande S, Legoix P, Lameiras S; HCC-AI study group; Bruges L, Gnemmi V, Nault JC, Campani C, Rhee H, Park YN, Iñarrairaegui M, Garcia-Porrero G, Argemi J, Sangro B, D'Alessio A, Scheiner B, Pinato DJ, Pinter M, Paradis V, Beaufrère A, Peter S, Rimassa L, Di Tommaso L, Vogel A, Michalak S, Boursier J, Loménie N, Ziol M, Calderaro J. Zeng Q, et al. Among authors: argemi j. Lancet Oncol. 2023 Dec;24(12):1411-1422. doi: 10.1016/S1470-2045(23)00468-0. Epub 2023 Nov 8. Lancet Oncol. 2023. PMID: 37951222
The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study.
Morales-Arráez D, Ventura-Cots M, Altamirano J, Abraldes JG, Cruz-Lemini M, Thursz MR, Atkinson SR, Sarin SK, Kim W, Chavez-Araujo R, Higuera-de la Tijera MF, Singal AK, Shah VH, Kamath PS, Duarte-Rojo A, Charles EA, Vargas V, Jager M, Rautou PE, Rincon D, Zamarripa F, Restrepo-Gutiérrez JC, Torre A, Lucey MR, Arab JP, Mathurin P, Louvet A, García-Tsao G, González JA, Verna EC, Brown RS Jr, Argemi J, Fernández-Carrillo C, Clemente A, Alvarado-Tapias E, Forrest E, Allison M, Bataller R. Morales-Arráez D, et al. Among authors: argemi j. Am J Gastroenterol. 2022 Feb 1;117(2):301-310. doi: 10.14309/ajg.0000000000001596. Am J Gastroenterol. 2022. PMID: 34962498 Free PMC article.
Immunotherapy in HCC-No rush despite the hype.
Sangro B, Argemí J. Sangro B, et al. Among authors: argemi j. Hepatology. 2022 Oct;76(4):906-908. doi: 10.1002/hep.32550. Epub 2022 May 19. Hepatology. 2022. PMID: 35491442 No abstract available.
Synergistic effects of combined immunotherapy strategies in a model of multifocal hepatocellular carcinoma.
Ochoa MC, Sanchez-Gregorio S, de Andrea CE, Garasa S, Alvarez M, Olivera I, Glez-Vaz J, Luri-Rey C, Etxeberria I, Cirella A, Azpilikueta A, Berraondo P, Argemi J, Sangro B, Teijeira A, Melero I. Ochoa MC, et al. Among authors: argemi j. Cell Rep Med. 2023 Apr 18;4(4):101009. doi: 10.1016/j.xcrm.2023.101009. Epub 2023 Apr 10. Cell Rep Med. 2023. PMID: 37040772 Free PMC article.
Identifying New Epigenetic Drivers of Liver Fibrosis.
Argemi J, Bataller R. Argemi J, et al. Cell Mol Gastroenterol Hepatol. 2019;7(1):237-238. doi: 10.1016/j.jcmgh.2018.09.015. Epub 2018 Oct 19. Cell Mol Gastroenterol Hepatol. 2019. PMID: 30539791 Free PMC article. No abstract available.
111 results